HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salvatore Venuta Selected Research

SANT-7

6/2005Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
10/2002The IL-6 receptor super-antagonist Sant7 enhances antiproliferative and apoptotic effects induced by dexamethasone and zoledronic acid on multiple myeloma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Salvatore Venuta Research Topics

Disease

22Neoplasms (Cancer)
01/2017 - 04/2002
6Multiple Myeloma
10/2007 - 10/2002
3Breast Neoplasms (Breast Cancer)
01/2007 - 05/2005
2Carcinogenesis
10/2006 - 07/2006
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2005 - 09/2003
2Carcinoma (Carcinomatosis)
08/2004 - 07/2002
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2008
1Lung Neoplasms (Lung Cancer)
05/2008
1Kidney Neoplasms (Kidney Cancer)
07/2007
1Genomic Instability
07/2006
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2006
1Brain Neoplasms (Brain Tumor)
01/2006
1Endometrial Neoplasms (Endometrial Cancer)
10/2005
1Leukemia
08/2005
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2005
1Teratoma (Teratoid Tumor)
03/2005
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2005
1Embryonal Carcinoma
03/2005
1Seminoma
03/2005
1Pleural Effusion (Pleural Effusions)
01/2005
1Melanoma (Melanoma, Malignant)
12/2004
1Hydronephrosis
09/2004
1Transitional Cell Carcinoma
09/2004
1Carcinosarcoma
09/2004
1Ovarian Neoplasms (Ovarian Cancer)
08/2004
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
07/2004
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2004
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2004
1Colonic Neoplasms (Colon Cancer)
04/2003
1Fallopian Tube Neoplasms
03/2003

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
12/2008 - 04/2003
4Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
10/2007 - 10/2002
3Pharmaceutical PreparationsIBA
08/2005 - 07/2004
3ParaproteinsIBA
08/2005 - 07/2004
3Interleukin-6 (Interleukin 6)IBA
07/2005 - 10/2002
3Messenger RNA (mRNA)IBA
03/2005 - 03/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017 - 05/2008
2Ferredoxins (Ferredoxin)IBA
01/2017 - 05/2008
2Oxidoreductases (Dehydrogenase)IBA
01/2017 - 05/2008
2tipifarnib (R115777)IBA
11/2007 - 09/2004
2TransferasesIBA
11/2007 - 09/2004
2BRCA1 ProteinIBA
01/2007 - 07/2006
2Sirolimus (Rapamycin)FDA Link
08/2005 - 12/2004
2NF-kappa B (NF-kB)IBA
08/2005 - 12/2004
2SANT-7IBA
06/2005 - 10/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
06/2005 - 10/2002
2Epidermal Growth Factor (EGF)IBA
01/2005 - 09/2004
2Immunoconjugates (Immunoconjugate)IBA
12/2004 - 07/2004
2Zoledronic Acid (Zometa)FDA Link
09/2004 - 10/2002
2AntigensIBA
07/2002 - 04/2002
1fragile histidine triad proteinIBA
05/2008
1Biomarkers (Surrogate Marker)IBA
10/2007
1B-Cell Activating FactorIBA
10/2007
1Interleukin-2 (IL2)IBA
07/2007
1Interleukin-2 Receptors (IL 2 Receptor)IBA
07/2007
1Folate Receptor 1IBA
01/2007
1ProteomeIBA
01/2007
1NucleotidesIBA
10/2006
1Amino AcidsFDA Link
07/2006
1Oncogene Proteins (Oncogene Protein)IBA
02/2006
1liposomal doxorubicin (Doxil)FDA Link
01/2006
1Temozolomide (Temodar)FDA LinkGeneric
01/2006
1ImmunophilinsIBA
08/2005
1TOR Serine-Threonine KinasesIBA
08/2005
1Phosphatidylinositols (Phosphatidylinositol)IBA
08/2005
1Phosphotransferases (Kinase)IBA
08/2005
1RNA (Ribonucleic Acid)IBA
08/2005
1Rituximab (Mabthera)FDA Link
08/2005
1GlucocorticoidsIBA
06/2005
1Vinorelbine (Navelbine)FDA LinkGeneric
05/2005
1PoisonsIBA
05/2005
1Docetaxel (Taxotere)FDA Link
05/2005
1Antineoplastic Agents (Antineoplastics)IBA
05/2005
1Taxoids (Taxanes)IBA
05/2005
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
03/2005
1Histocompatibility Antigens Class IIBA
01/2005
1Interferon-alpha (Interferon Alfa)IBA
01/2005
1micaIBA
01/2005
1MacrolidesIBA
12/2004
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2004
1Pamidronate (Aredia)FDA LinkGeneric
09/2004
1Cisplatin (Platino)FDA LinkGeneric
09/2004
1GemcitabineFDA Link
09/2004
1Cytotoxins (Cytolysins)IBA
07/2004
1Ado-Trastuzumab EmtansineIBA
07/2004
1Complementary DNA (cDNA)IBA
03/2004
1CytokinesIBA
03/2004
1Transcription Factors (Transcription Factor)IBA
03/2004
1ElementsIBA
03/2004
1RacivirIBA
03/2003
1SialoglycoproteinsIBA
07/2002
1Biological ProductsIBA
04/2002

Therapy/Procedure

2Therapeutics
01/2007 - 06/2005
1Laparotomy
10/2005
1Urinary Diversion (Ileal Conduit)
09/2004
1Drug Therapy (Chemotherapy)
09/2004
1Ovariectomy (Oophorectomy)
08/2004